Lumigenex is a nanotechnology-driven provider of POCT products to the clinical laboratories and doctor offices. It specializes in developing and manufacturing of quantitative POCT readers and diagnostic kits based on its proprietary TRFIA platform to detect cardiovascular diseases, women's health, and infectious diseases. Numerous COVID-19 rapid tests are developed. We also offer convenient dry chemistry analyzers to manage chronic diseases by measuring lipids, glucose and uric acids and etc.